pI: 5.1743 |
Length (AA): 692 |
MW (Da): 79529 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
4 | 104 | 2ctw (A) | 8 | 105 | 28.00 | 0 | 1 | 0.49 | -0.02 |
18 | 79 | 2cug (A) | 20 | 79 | 43.00 | 0.000042 | 1 | 0.66 | -0.83 |
7 | 81 | 2ej7 (A) | 1 | 75 | 47.00 | 0.00023 | 1 | 0.709982 | -0.73 |
12 | 84 | 3ucs (C) | 1 | 71 | 37.00 | 0.21 | 1 | 0.676091 | -1.62 |
14 | 84 | 2lgw (A) | 1 | 71 | 45.00 | 0.00034 | 1 | 0.690201 | -0.79 |
17 | 110 | 3apq (A) | 36 | 118 | 36.00 | 0.00015 | 1 | 0.479738 | -0.22 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Tachyzoite, ME49 Oocyst. | Gregory Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 merozoite, ME49 Bradyzoite. | Gregory Hehl AB Sibley/Greg |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_128332)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G74250 | DNAJ heat shock N-terminal domain-containing protein |
Babesia bovis | BBOV_IV006710 | DnaJ domain containing protein |
Brugia malayi | Bm1_15665 | DnaJ domain containing protein |
Candida albicans | CaO19.9935 | DnaJ-like protein with two potential C2H2 Zn fingers similar to S. cerevisiae JJJ1 (YNL227C) |
Candida albicans | CaO19.2399 | DnaJ-like protein with two potential C2H2 Zn fingers similar to S. cerevisiae JJJ1 (YNL227C) |
Caenorhabditis elegans | CELE_T03F6.2 | Protein DNJ-17 |
Cryptosporidium hominis | Chro.50078 | hypothetical protein |
Cryptosporidium parvum | cgd5_2950 | DNAj domain protein |
Dictyostelium discoideum | DDB_G0286579 | hypothetical protein |
Drosophila melanogaster | Dmel_CG2790 | CG2790 gene product from transcript CG2790-RA |
Echinococcus granulosus | EgrG_000180500 | dnaJ subfamily C 1 |
Entamoeba histolytica | EHI_188830 | DnaJ domain containing protein |
Echinococcus multilocularis | EmuJ_000180500 | dnaJ subfamily C 1 |
Giardia lamblia | GL50803_16406 | Chaperone protein dnaJ |
Homo sapiens | ENSG00000168724 | DnaJ (Hsp40) homolog, subfamily C, member 21 |
Leishmania braziliensis | LbrM.25.1770 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_252290.1 | DnaJ domain/Zinc-finger double-stranded RNA-binding, putative |
Leishmania infantum | LinJ.25.2290 | hypothetical protein, conserved |
Leishmania major | LmjF.25.2190 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.25.2190 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_11616 | hypothetical protein |
Mus musculus | ENSMUSG00000044224 | DnaJ (Hsp40) homolog, subfamily C, member 21 |
Neospora caninum | NCLIV_012800 | F14N23.23, related |
Oryza sativa | 4352284 | Os12g0502700 |
Plasmodium berghei | PBANKA_1203800 | DnaJ protein, putative |
Plasmodium falciparum | PF3D7_1005600 | DnaJ protein, putative |
Plasmodium knowlesi | PKNH_0804300 | DnaJ protein, putative |
Plasmodium vivax | PVX_094470 | hypothetical protein |
Plasmodium yoelii | PY01286 | DnaJ domain, putative |
Saccharomyces cerevisiae | YNL227C | Jjj1p |
Schistosoma japonicum | Sjp_0072370 | ko:K09506 DnaJ homolog, subfamily A, member 5, putative |
Schistosoma mansoni | Smp_172510.2 | DNAj-related |
Schistosoma mansoni | Smp_172510.1 | DNAj-related |
Schmidtea mediterranea | mk4.002534.03 | DnaJ homolog subfamily C member 21 |
Trypanosoma brucei gambiense | Tbg972.3.2270 | chaperone protein DNAj, putative |
Trypanosoma brucei | Tb927.3.2290 | chaperone protein DnaJ, putative |
Trypanosoma congolense | TcIL3000_0_42300 | chaperone protein DnaJ, putative |
Trypanosoma cruzi | TcCLB.508479.280 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_301340 | DnaJ domain-containing protein |
Trichomonas vaginalis | TVAG_273650 | J protein type, putative |
Trichomonas vaginalis | TVAG_413330 | protein CAJ1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.2290 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.2290 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.2290 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.2290 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T03F6.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_1203800 | Plasmodium berghei | Dispensable | plasmo |
TGME49_301340 this record | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3